{
    "nctId": "NCT01823172",
    "briefTitle": "Second Echelon Node Study With Methylene Blue",
    "officialTitle": "Feasibility of Lymphatic Mapping of Second Echelon Lymph Nodes With Methylene Blue",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer, Melanoma",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "BASIC_SCIENCE",
    "enrollmentCount": 21,
    "primaryOutcomeMeasure": "The number of subjects in whom a secondary echelon lymph node is identified",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Histologically confirmed primary cutaneous melanoma located on the extremity or trunk\n* Patients with clinically stage I-II melanoma\n* Histologically confirmed invasive ductal or lobular carcinoma\n* Patient undergoing surgical treatment of breast primary and sentinel lymph node biopsy- clinically node negative\n\nExclusion Criteria:\n\n* Melanoma located on the head or neck, uveal or mucosal\n* Previous surgery or radiation in or near the sentinel lymph node biopsy nodal basin\n* Preoperative biopsy proven regional lymph node involvement\n* Failure of lymphatic mapping with radioactive colloid\n* Women who are pregnant or nursing\n* Prior ipsilateral axillary surgery or radiation\n* Inflammatory breast cancer\n* No lymph node identified in the ipsilateral breast during pathologic review of the mastectomy specimen\n* Stage IV breast cancer",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}